`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`EDWARDS LIFESCIENCES CORPORATION, EDWARDS
`LIFESCIENCES LLC, AND EDWARDS LIFESCIENCES AG
`Petitioners
`
`v.
`
`BOSTON SCIENTIFIC SCIMED, INC.
`Patent Owner
`_____________
`
`Case IPR2017-00060
`Patent 8,992,608
`_____________
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`U.S. Patent & Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`Exhibit No.
`
`Description
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`Sapien 3 Brochure, “Transcatheter Aortic Valve Replacement with
`the Edwards SAPIEN 3 Transcatheter Heart Valve”, 2016
`
`Press Release: FDA approves expanded indication for two
`transcatheter heart valves for patients at intermediate risk for death
`or complications associated with open-heart surgery, FDA
`8/18/2016
`
`Thourani, V. H., et al., Transcatheter aortic valve replacement
`versus surgical valve replacement in intermediate-risk patients : a
`propensity score analysis, The Lancet, Apr. 3, 2016
`
`Lerakis. et al., Paravalvular Aortic Leak After Transcatheter Aortic
`Valve Replacement Current Knowledge, Circulation, Jan. 22, 2013,
`p. 397-407
`
`Cribier et al., Mid-Term Experience of Percutaneous Heart Valves,
`JACC 47:1214:23 (2006)
`
`Bentall, H.H., De Bono, A.: A technique for complete replacement
`of the ascending aorta, Th orax , 23:338-39 (1968)
`
`Order re: Motions for Summary Judgment, Medtronic Inc. v.
`Edwards Lifesciences Corp., et al., No. 12-0327, Dkt. 414 (C.D.
`Cal. Sept. 17, 2013)
`
`Report and Recommendation at 11, n.6, W.L. Gore & Assocs. v.
`C.R. Bard, Inc., Civ. A. No. 11-515-LPS-CJB, Dkt. 428 (D. Del.
`Nov. 9, 2015)
`
`Declaration of Marc A. Cohn in Support of Motion for Pro Hac
`Vice Admission (May 9, 2017)
`
`Declaration of Matthew M. Wolf in Support of Motion for Pro Hac
`Vice Admission (May 9, 2017)
`
`-i-
`
`
`
`Exhibit No.
`
`Description
`
`2011
`
`Declaration of Edward Han in Support of Motion for Pro Hac Vice
`Admission (May 9, 2017)
`
`-ii-
`
`
`
`Dated: May 9, 2017
`
`Respectfully submitted,
`/Je nnife rA. Skle nar/
`Jennifer A. Sklenar (Reg. No. 40,205)
`Wallace Wu (Reg. No.45,380)
`ARNOLD & PORTER KAYE
`SCHOLER LLP
`777 S. Figueroa Street, 44th Floor
`Los Angeles, CA 90017-5844
`Tel:
`(213) 243-4000
`Fax: (213) 243-4199
`
`Attorne ysforPate nt Owne rBoston
`Scie ntific Scim e d, Inc.
`
`-1-
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing document was served
`
`on May 9, 2017, to the following Counsel for Petitioners via e-mail:
`
`Gregory S. Cordrey (Reg. No. 44,089)
`Jeffer Mangels Butler & Mitchell, LLP
`3 Park Plaza, Suite 1100
`Irvine, CA 92614
`Email: gcordrey@jmbm.com
`Telephone: 949-623-7200
`Facsimile: 949-623-7201
`
`Brian Egan (Reg. No. 54,866)
`Morris, Nichols, Arsht & Tunnell
`LLP
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899-1347
`Email: began@MNAT.com
`Telephone: 302-351-9454
`Facsimile: 302-498-6216
`
`Catherine Nyarady (Reg. No. 42,042)
`Paul, Weiss, Rifkind, Wharton &
`Garrison LLP
`1285 Avenue of the Americas
`New York, NY 10019
`Email: cnyarady@paulweiss.com
`Telephone: 212-373-3532
`Facsimile: 212-492-0532
`
`Attorne ysforPe titione rs
`Edwards Lifesciences Corporation, Edwards Lifesciences LLC, and Edwards
`Lifesciences AG
`
`/Je nnife rA. Skle nar/
`Jennifer A. Sklenar (Reg. No. 40,205)
`ARNOLD & PORTER KAYE
`SCHOLER LLP
`777 S. Figueroa Street, 44th Floor
`Los Angeles, CA 90017-5844
`Tel:
`(213) 243-4000
`Fax: (213) 243-4199
`
`-2-
`
`